TERAZOSIN HYDROCHLORIDE ANHYDROUS
UNII 8QOP8Z9955

Substance Identification & Data

This profile provides standardized clinical and technical data for Terazosin Hydrochloride Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8QOP8Z9955.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 63074-08-8 and the RxNorm Concept ID (RxCUI) 1299927. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8QOP8Z9955

CAS Registry Number

63074-08-8

RxNorm Concept ID

1299927

Detailed Substance Profile

Preferred Name

TERAZOSIN HYDROCHLORIDE ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H25N5O4.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IWSWDOUXSCRCKW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C75056

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

44383

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(nc(N)c2c(n1)cc(c(OC)c2)OC)N3CCN(C(C4OCCC4)=O)CC3.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Terazosin Hydrochloride Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.